Stimulant-atypical antipsychotic interaction and acute dystonia [3]

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 44, Issue 6, 2005, Pages 510-512

  Benjamin, Eric ^a   Salek, Sara ^b  

^a PHOENIX CHILDREN'S HOSPITAL   (United States)

^b BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZATROPINE; CENTRAL STIMULANT AGENT; CLONIDINE; DEXAMPHETAMINE; FLUVOXAMINE; GUANFACINE; METHYLPHENIDATE; OLANZAPINE; RISPERIDONE; VALPROIC ACID;

ADOLESCENT; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CASE REPORT; COMORBIDITY; DRUG WITHDRAWAL; DYSTONIA; GILLES DE LA TOURETTE SYNDROME; HOSPITALIZATION; HUMAN; LETTER; MALE; MENTAL DEFICIENCY; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 19344363749     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000159166.96967.13     Document Type: Letter

References (5)

1. Casey DE (1992), Acute neuroleptic-induced dystonia. In: Movement Disorders in Neurology and Neuropsychiatry, Joseph, AB, Young RR, eds. Boston: Blackwell, pp 106-110
2. Conner DF, Benjamin S, Ozbayrak K (1995), Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment. J Am Acad Child Adolesc Psychiatry 34:1490-1494
3. Ding YS, Fowler JS, Volkow ND et al. (1994), Pharmacokinetics and in vivo specificity of [11C]di-threo-methylphenidate for the presynaptic dopaminergic neuron. Synapse 18:152-160
4. Lang AE (1985), Review: dopamine agonists in the treatment of dystonia. Clin Neuropharmacol 8:38-57
5. Laurelle M, Abi-Dargham A, van Dyck CH et al. (1995), SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med 36:1182-1190